Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Vaxart, Inc. | Director | Common Stock | 6.22K | $14.9K | $2.39 | Aug 4, 2022 | Direct |
Vaxart, Inc. | Director | Stock Option (right to buy) | 37.3K | Aug 4, 2022 | Direct | ||
Elevation Oncology, Inc. | Director | Stock Option (Right to Buy) | 35K | Jun 13, 2024 | Direct | ||
Mirati Therapeutics, Inc. | Director | Common Stock | 0 | $59.02 | Jan 23, 2024 | Direct | |
Mirati Therapeutics, Inc. | Director | Option to Purchase Common Stock | 0 | Jan 23, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ELEV | Elevation Oncology, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
ELEV | Elevation Oncology, Inc. | Feb 29, 2024 | 1 | $0 | 4 | Mar 4, 2024 | Director |
ELEV | Elevation Oncology, Inc. | Feb 29, 2024 | 0 | $0 | 3 | Mar 4, 2024 | Director |
MRTX | Mirati Therapeutics, Inc. | Jan 23, 2024 | 3 | $0 | 4 | Jan 23, 2024 | Director |
MRTX | Mirati Therapeutics, Inc. | Dec 29, 2023 | 1 | $400K | 4 | Jan 3, 2024 | Director |
MRTX | Mirati Therapeutics, Inc. | Jan 20, 2023 | 2 | $0 | 4 | Jan 24, 2023 | Director |
MRTX | Mirati Therapeutics, Inc. | Jan 18, 2023 | 1 | -$114K | 4 | Jan 20, 2023 | Director |
VXRT | Vaxart, Inc. | Aug 4, 2022 | 2 | $0 | 4 | Aug 8, 2022 | Director |
MRTX | Mirati Therapeutics, Inc. | Jan 19, 2022 | 1 | -$171K | 4 | Jan 20, 2022 | Director |
MRTX | Mirati Therapeutics, Inc. | Jan 14, 2022 | 2 | $0 | 4 | Jan 18, 2022 | Director |
VXRT | Vaxart, Inc. | Aug 20, 2021 | 1 | $0 | 4 | Aug 23, 2021 | Director |
VXRT | Vaxart, Inc. | Aug 20, 2021 | 0 | $0 | 3 | Aug 23, 2021 | Director |